|
RFWD3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.212000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.614200E-01 |
| Normal-vs-Stage2 |
5.807800E-01 |
| Normal-vs-Stage3 |
1.574950E-01 |
| Normal-vs-Stage4 |
6.890000E-02 |
| Stage1-vs-Stage2 |
8.810600E-01 |
| Stage1-vs-Stage3 |
1.938200E-01 |
| Stage1-vs-Stage4 |
1.391030E-01 |
| Stage2-vs-Stage3 |
4.894400E-01 |
| Stage2-vs-Stage4 |
3.184400E-01 |
| Stage3-vs-Stage4 |
6.629000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.105600E-01 |
| Normal-vs-AfricanAmerican |
2.918600E-01 |
| Normal-vs-Asian |
7.118400E-01 |
| Caucasian-vs-AfricanAmerican |
5.978200E-01 |
| Caucasian-vs-Asian |
2.300800E-01 |
| AfricanAmerican-vs-Asian |
2.039800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.372400E-01 |
| Normal-vs-Female |
3.417800E-01 |
| Male-vs-Female |
9.075600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.817600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.362400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.501800E-02 |
| Normal-vs-Age(81-100Yrs) |
5.450000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.357220E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.626000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.238800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.963200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.934000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.796800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.330190E-01 |
| Classical-VS-Follicular |
1.7168999999484E-06 |
| Classical-VS-Other |
2.248800E-01 |
| Classical-VS-Normal |
8.000600E-01 |
| Tall-VS-Follicular |
1.849840E-01 |
| Tall-VS-Other |
6.906400E-01 |
| Tall-VS-Normal |
2.698400E-01 |
| Follicular-VS-Other |
7.338000E-01 |
| Follicular-VS-Normal |
3.835100E-03 |
| Other-VS-Normal |
2.804200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.543430E-01 |
| Normal-vs-N1 |
1.562440E-01 |
| N0-vs-N1 |
8.043000E-01 |
|
|
